Trial intelligence / Profile preview

Transformation of Paraplegic Paralysis to Overground Stepping in Humans

NCT04105114Phase 1Active, not recruiting

Sponsor
University of Louisville
Start
Sep 2019
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of buspirone in spinal cord injury (SCI) (3 arms), sponsored by University of Louisville. Primary endpoints: Lower Extremity Electromyography, Lower Extremity Kinematics and 14 more. Started Sep 2019; status: active, not recruiting.

02

Drugs

buspirone
03

Conditions

spinal cord injury (SCI)

Beyond the preview

Go deeper on NCT04105114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04105114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call